ResMed Inc.
ResMed Inc. (RSMDF) Stock Competitors & Peer Comparison
See (RSMDF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RSMDF | $17.93 | +0.00% | 26B | 17.24 | $1.04 | +1.16% |
| SEMHF | $41.07 | +1.49% | 46B | 18.67 | $2.20 | +2.94% |
| RYLPF | $26.98 | -0.91% | 25.7B | 23.26 | $1.16 | +3.69% |
| FUJIY | $10.44 | +4.25% | 25.2B | 14.70 | $0.71 | +3.31% |
| FUJIF | $20.00 | +0.00% | 23.9B | 14.18 | $1.41 | +2.28% |
| SMMNY | $20.29 | -0.42% | 22.7B | 18.44 | $1.10 | +2.92% |
| SONVF | $268.00 | +0.00% | 15.9B | 23.30 | $11.50 | +2.02% |
| SONVY | $52.48 | -1.69% | 15.6B | 22.92 | $2.29 | +2.02% |
| CLPBY | $6.23 | -2.35% | 14B | 41.53 | $0.15 | +5.68% |
| SNNUF | $14.91 | +0.00% | 12.7B | 20.71 | $0.72 | +2.60% |
Stock Comparison
RSMDF vs SEMHF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, SEMHF has a market cap of 46B. Regarding current trading prices, RSMDF is priced at $17.93, while SEMHF trades at $41.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas SEMHF's P/E ratio is 18.67. In terms of profitability, RSMDF's ROE is +0.24%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, RSMDF is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check SEMHF's competition here
RSMDF vs RYLPF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, RYLPF has a market cap of 25.7B. Regarding current trading prices, RSMDF is priced at $17.93, while RYLPF trades at $26.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas RYLPF's P/E ratio is 23.26. In terms of profitability, RSMDF's ROE is +0.24%, compared to RYLPF's ROE of +0.09%. Regarding short-term risk, RSMDF is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check RYLPF's competition here
RSMDF vs FUJIY Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, FUJIY has a market cap of 25.2B. Regarding current trading prices, RSMDF is priced at $17.93, while FUJIY trades at $10.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas FUJIY's P/E ratio is 14.70. In terms of profitability, RSMDF's ROE is +0.24%, compared to FUJIY's ROE of +0.08%. Regarding short-term risk, RSMDF is more volatile compared to FUJIY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check FUJIY's competition here
RSMDF vs FUJIF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, FUJIF has a market cap of 23.9B. Regarding current trading prices, RSMDF is priced at $17.93, while FUJIF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas FUJIF's P/E ratio is 14.18. In terms of profitability, RSMDF's ROE is +0.24%, compared to FUJIF's ROE of +0.10%. Regarding short-term risk, RSMDF is more volatile compared to FUJIF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check FUJIF's competition here
RSMDF vs SMMNY Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, SMMNY has a market cap of 22.7B. Regarding current trading prices, RSMDF is priced at $17.93, while SMMNY trades at $20.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas SMMNY's P/E ratio is 18.44. In terms of profitability, RSMDF's ROE is +0.24%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, RSMDF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check SMMNY's competition here
RSMDF vs SONVF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, SONVF has a market cap of 15.9B. Regarding current trading prices, RSMDF is priced at $17.93, while SONVF trades at $268.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas SONVF's P/E ratio is 23.30. In terms of profitability, RSMDF's ROE is +0.24%, compared to SONVF's ROE of +0.21%. Regarding short-term risk, RSMDF is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check SONVF's competition here
RSMDF vs SONVY Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, SONVY has a market cap of 15.6B. Regarding current trading prices, RSMDF is priced at $17.93, while SONVY trades at $52.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas SONVY's P/E ratio is 22.92. In terms of profitability, RSMDF's ROE is +0.24%, compared to SONVY's ROE of +0.22%. Regarding short-term risk, RSMDF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check SONVY's competition here
RSMDF vs CLPBY Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, CLPBY has a market cap of 14B. Regarding current trading prices, RSMDF is priced at $17.93, while CLPBY trades at $6.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas CLPBY's P/E ratio is 41.53. In terms of profitability, RSMDF's ROE is +0.24%, compared to CLPBY's ROE of +0.14%. Regarding short-term risk, RSMDF is more volatile compared to CLPBY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check CLPBY's competition here
RSMDF vs SNNUF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, SNNUF has a market cap of 12.7B. Regarding current trading prices, RSMDF is priced at $17.93, while SNNUF trades at $14.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas SNNUF's P/E ratio is 20.71. In terms of profitability, RSMDF's ROE is +0.24%, compared to SNNUF's ROE of +0.12%. Regarding short-term risk, RSMDF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check SNNUF's competition here
RSMDF vs CLPBF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, CLPBF has a market cap of 12.4B. Regarding current trading prices, RSMDF is priced at $17.93, while CLPBF trades at $59.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas CLPBF's P/E ratio is 41.17. In terms of profitability, RSMDF's ROE is +0.24%, compared to CLPBF's ROE of +0.14%. Regarding short-term risk, RSMDF is more volatile compared to CLPBF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check CLPBF's competition here
RSMDF vs OCPNF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, OCPNF has a market cap of 12.3B. Regarding current trading prices, RSMDF is priced at $17.93, while OCPNF trades at $11.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas OCPNF's P/E ratio is 29.42. In terms of profitability, RSMDF's ROE is +0.24%, compared to OCPNF's ROE of +0.09%. Regarding short-term risk, RSMDF is more volatile compared to OCPNF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check OCPNF's competition here
RSMDF vs WILYY Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, WILYY has a market cap of 7.9B. Regarding current trading prices, RSMDF is priced at $17.93, while WILYY trades at $18.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas WILYY's P/E ratio is 21.63. In terms of profitability, RSMDF's ROE is +0.24%, compared to WILYY's ROE of +0.16%. Regarding short-term risk, RSMDF is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check WILYY's competition here
RSMDF vs WILLF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, WILLF has a market cap of 7.5B. Regarding current trading prices, RSMDF is priced at $17.93, while WILLF trades at $35.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas WILLF's P/E ratio is 20.37. In terms of profitability, RSMDF's ROE is +0.24%, compared to WILLF's ROE of +0.16%. Regarding short-term risk, RSMDF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check WILLF's competition here
RSMDF vs GNGBY Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, GNGBY has a market cap of 5.5B. Regarding current trading prices, RSMDF is priced at $17.93, while GNGBY trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas GNGBY's P/E ratio is 21.85. In terms of profitability, RSMDF's ROE is +0.24%, compared to GNGBY's ROE of +0.08%. Regarding short-term risk, RSMDF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check GNGBY's competition here
RSMDF vs GNGBF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, GNGBF has a market cap of 5.1B. Regarding current trading prices, RSMDF is priced at $17.93, while GNGBF trades at $20.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas GNGBF's P/E ratio is 21.79. In terms of profitability, RSMDF's ROE is +0.24%, compared to GNGBF's ROE of +0.08%. Regarding short-term risk, RSMDF is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check GNGBF's competition here
RSMDF vs YPHDF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, YPHDF has a market cap of 4.7B. Regarding current trading prices, RSMDF is priced at $17.93, while YPHDF trades at $354.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas YPHDF's P/E ratio is 17.06. In terms of profitability, RSMDF's ROE is +0.24%, compared to YPHDF's ROE of +0.38%. Regarding short-term risk, RSMDF is more volatile compared to YPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check YPHDF's competition here
RSMDF vs CHEOY Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, CHEOY has a market cap of 4.6B. Regarding current trading prices, RSMDF is priced at $17.93, while CHEOY trades at $35.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas CHEOY's P/E ratio is 18.57. In terms of profitability, RSMDF's ROE is +0.24%, compared to CHEOY's ROE of +0.18%. Regarding short-term risk, RSMDF is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check CHEOY's competition here
RSMDF vs CHEOF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, CHEOF has a market cap of 4.4B. Regarding current trading prices, RSMDF is priced at $17.93, while CHEOF trades at $67.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas CHEOF's P/E ratio is 17.85. In terms of profitability, RSMDF's ROE is +0.24%, compared to CHEOF's ROE of +0.18%. Regarding short-term risk, RSMDF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check CHEOF's competition here
RSMDF vs NHNKY Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, NHNKY has a market cap of 2.9B. Regarding current trading prices, RSMDF is priced at $17.93, while NHNKY trades at $9.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas NHNKY's P/E ratio is 16.17. In terms of profitability, RSMDF's ROE is +0.24%, compared to NHNKY's ROE of +0.08%. Regarding short-term risk, RSMDF is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check NHNKY's competition here
RSMDF vs AMBBY Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, AMBBY has a market cap of 2.7B. Regarding current trading prices, RSMDF is priced at $17.93, while AMBBY trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas AMBBY's P/E ratio is 36.43. In terms of profitability, RSMDF's ROE is +0.24%, compared to AMBBY's ROE of +0.08%. Regarding short-term risk, RSMDF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check AMBBY's competition here
RSMDF vs AMFPF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, AMFPF has a market cap of 2.6B. Regarding current trading prices, RSMDF is priced at $17.93, while AMFPF trades at $12.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas AMFPF's P/E ratio is 33.36. In terms of profitability, RSMDF's ROE is +0.24%, compared to AMFPF's ROE of +0.07%. Regarding short-term risk, RSMDF is more volatile compared to AMFPF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check AMFPF's competition here
RSMDF vs AMBFF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, AMBFF has a market cap of 2.6B. Regarding current trading prices, RSMDF is priced at $17.93, while AMBFF trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas AMBFF's P/E ratio is 35.36. In terms of profitability, RSMDF's ROE is +0.24%, compared to AMBFF's ROE of +0.08%. Regarding short-term risk, RSMDF is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check AMBFF's competition here
RSMDF vs NHNKF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, NHNKF has a market cap of 2.4B. Regarding current trading prices, RSMDF is priced at $17.93, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, RSMDF's ROE is +0.24%, compared to NHNKF's ROE of +0.08%. Regarding short-term risk, RSMDF is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check NHNKF's competition here
RSMDF vs GNNDY Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, GNNDY has a market cap of 2.2B. Regarding current trading prices, RSMDF is priced at $17.93, while GNNDY trades at $45.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas GNNDY's P/E ratio is 53.77. In terms of profitability, RSMDF's ROE is +0.24%, compared to GNNDY's ROE of -0.04%. Regarding short-term risk, RSMDF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check GNNDY's competition here
RSMDF vs MCRPF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, MCRPF has a market cap of 2.2B. Regarding current trading prices, RSMDF is priced at $17.93, while MCRPF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas MCRPF's P/E ratio is -12.67. In terms of profitability, RSMDF's ROE is +0.24%, compared to MCRPF's ROE of +0.06%. Regarding short-term risk, RSMDF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check MCRPF's competition here
RSMDF vs GGNDF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, RSMDF is priced at $17.93, while GGNDF trades at $14.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas GGNDF's P/E ratio is 52.14. In terms of profitability, RSMDF's ROE is +0.24%, compared to GGNDF's ROE of -0.04%. Regarding short-term risk, RSMDF is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check GGNDF's competition here
RSMDF vs DRWKF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, DRWKF has a market cap of 2.1B. Regarding current trading prices, RSMDF is priced at $17.93, while DRWKF trades at $111.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas DRWKF's P/E ratio is 11.78. In terms of profitability, RSMDF's ROE is +0.24%, compared to DRWKF's ROE of +0.10%. Regarding short-term risk, RSMDF is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check DRWKF's competition here
RSMDF vs OSSFF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, OSSFF has a market cap of 1.8B. Regarding current trading prices, RSMDF is priced at $17.93, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas OSSFF's P/E ratio is 20.75. In terms of profitability, RSMDF's ROE is +0.24%, compared to OSSFF's ROE of +0.10%. Regarding short-term risk, RSMDF is more volatile compared to OSSFF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check OSSFF's competition here
RSMDF vs DWRKF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, RSMDF is priced at $17.93, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, RSMDF's ROE is +0.24%, compared to DWRKF's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check DWRKF's competition here
RSMDF vs MEDGF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, RSMDF is priced at $17.93, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, RSMDF's ROE is +0.24%, compared to MEDGF's ROE of +0.22%. Regarding short-term risk, RSMDF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check MEDGF's competition here
RSMDF vs BOEUF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, BOEUF has a market cap of 1.6B. Regarding current trading prices, RSMDF is priced at $17.93, while BOEUF trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas BOEUF's P/E ratio is 83.30. In terms of profitability, RSMDF's ROE is +0.24%, compared to BOEUF's ROE of +0.22%. Regarding short-term risk, RSMDF is more volatile compared to BOEUF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check BOEUF's competition here
RSMDF vs OSSUY Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, OSSUY has a market cap of 1.6B. Regarding current trading prices, RSMDF is priced at $17.93, while OSSUY trades at $3.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas OSSUY's P/E ratio is 19.08. In terms of profitability, RSMDF's ROE is +0.24%, compared to OSSUY's ROE of +0.10%. Regarding short-term risk, RSMDF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check OSSUY's competition here
RSMDF vs DGWPF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, DGWPF has a market cap of 1.6B. Regarding current trading prices, RSMDF is priced at $17.93, while DGWPF trades at $83.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas DGWPF's P/E ratio is 8.76. In terms of profitability, RSMDF's ROE is +0.24%, compared to DGWPF's ROE of +0.10%. Regarding short-term risk, RSMDF is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check DGWPF's competition here
RSMDF vs VTRLY Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, VTRLY has a market cap of 1.5B. Regarding current trading prices, RSMDF is priced at $17.93, while VTRLY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas VTRLY's P/E ratio is -2.77. In terms of profitability, RSMDF's ROE is +0.24%, compared to VTRLY's ROE of -0.47%. Regarding short-term risk, RSMDF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check VTRLY's competition here
RSMDF vs MDRSF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, MDRSF has a market cap of 1.4B. Regarding current trading prices, RSMDF is priced at $17.93, while MDRSF trades at $115.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas MDRSF's P/E ratio is 135.29. In terms of profitability, RSMDF's ROE is +0.24%, compared to MDRSF's ROE of +0.03%. Regarding short-term risk, RSMDF is more volatile compared to MDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check MDRSF's competition here
RSMDF vs FDMDF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, FDMDF has a market cap of 1.3B. Regarding current trading prices, RSMDF is priced at $17.93, while FDMDF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas FDMDF's P/E ratio is -7.76. In terms of profitability, RSMDF's ROE is +0.24%, compared to FDMDF's ROE of -9.21%. Regarding short-term risk, RSMDF is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check FDMDF's competition here
RSMDF vs ELEAF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, ELEAF has a market cap of 1.3B. Regarding current trading prices, RSMDF is priced at $17.93, while ELEAF trades at $15.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas ELEAF's P/E ratio is 20.69. In terms of profitability, RSMDF's ROE is +0.24%, compared to ELEAF's ROE of +0.16%. Regarding short-term risk, RSMDF is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check ELEAF's competition here
RSMDF vs LFTSF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, RSMDF is priced at $17.93, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, RSMDF's ROE is +0.24%, compared to LFTSF's ROE of +0.02%. Regarding short-term risk, RSMDF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check LFTSF's competition here
RSMDF vs XVIPF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, XVIPF has a market cap of 925.8M. Regarding current trading prices, RSMDF is priced at $17.93, while XVIPF trades at $29.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas XVIPF's P/E ratio is 117.56. In terms of profitability, RSMDF's ROE is +0.24%, compared to XVIPF's ROE of +0.03%. Regarding short-term risk, RSMDF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check XVIPF's competition here
RSMDF vs BRSYF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, BRSYF has a market cap of 674.4M. Regarding current trading prices, RSMDF is priced at $17.93, while BRSYF trades at $16.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas BRSYF's P/E ratio is 76.55. In terms of profitability, RSMDF's ROE is +0.24%, compared to BRSYF's ROE of +0.12%. Regarding short-term risk, RSMDF is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check BRSYF's competition here
RSMDF vs CALZF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, CALZF has a market cap of 616.1M. Regarding current trading prices, RSMDF is priced at $17.93, while CALZF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas CALZF's P/E ratio is 89.18. In terms of profitability, RSMDF's ROE is +0.24%, compared to CALZF's ROE of +0.12%. Regarding short-term risk, RSMDF is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check CALZF's competition here
RSMDF vs IOBCF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, IOBCF has a market cap of 528.5M. Regarding current trading prices, RSMDF is priced at $17.93, while IOBCF trades at $18.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas IOBCF's P/E ratio is 36.78. In terms of profitability, RSMDF's ROE is +0.24%, compared to IOBCF's ROE of +0.10%. Regarding short-term risk, RSMDF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check IOBCF's competition here
RSMDF vs AVMR Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, RSMDF is priced at $17.93, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas AVMR's P/E ratio is -18.34. In terms of profitability, RSMDF's ROE is +0.24%, compared to AVMR's ROE of -0.23%. Regarding short-term risk, RSMDF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check AVMR's competition here
RSMDF vs HYBT Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, RSMDF is priced at $17.93, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas HYBT's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.24%, compared to HYBT's ROE of +0.02%. Regarding short-term risk, RSMDF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check HYBT's competition here
RSMDF vs CSSPF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, CSSPF has a market cap of 336.4M. Regarding current trading prices, RSMDF is priced at $17.93, while CSSPF trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas CSSPF's P/E ratio is 39.98. In terms of profitability, RSMDF's ROE is +0.24%, compared to CSSPF's ROE of +0.10%. Regarding short-term risk, RSMDF is more volatile compared to CSSPF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check CSSPF's competition here
RSMDF vs CLVSF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, CLVSF has a market cap of 321.8M. Regarding current trading prices, RSMDF is priced at $17.93, while CLVSF trades at $13.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas CLVSF's P/E ratio is 22.48. In terms of profitability, RSMDF's ROE is +0.24%, compared to CLVSF's ROE of +0.15%. Regarding short-term risk, RSMDF is more volatile compared to CLVSF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check CLVSF's competition here
RSMDF vs CYBQY Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, CYBQY has a market cap of 303.2M. Regarding current trading prices, RSMDF is priced at $17.93, while CYBQY trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas CYBQY's P/E ratio is -170.00. In terms of profitability, RSMDF's ROE is +0.24%, compared to CYBQY's ROE of +0.01%. Regarding short-term risk, RSMDF is more volatile compared to CYBQY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check CYBQY's competition here
RSMDF vs DMTRF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, DMTRF has a market cap of 270.5M. Regarding current trading prices, RSMDF is priced at $17.93, while DMTRF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas DMTRF's P/E ratio is -112.50. In terms of profitability, RSMDF's ROE is +0.24%, compared to DMTRF's ROE of +0.36%. Regarding short-term risk, RSMDF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.Check DMTRF's competition here
RSMDF vs CYBQF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, CYBQF has a market cap of 246.8M. Regarding current trading prices, RSMDF is priced at $17.93, while CYBQF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas CYBQF's P/E ratio is -185.00. In terms of profitability, RSMDF's ROE is +0.24%, compared to CYBQF's ROE of +0.00%. Regarding short-term risk, RSMDF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check CYBQF's competition here
RSMDF vs HTLZF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, RSMDF is priced at $17.93, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, RSMDF's ROE is +0.24%, compared to HTLZF's ROE of -0.01%. Regarding short-term risk, RSMDF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check HTLZF's competition here
RSMDF vs IMPZY Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, IMPZY has a market cap of 229.3M. Regarding current trading prices, RSMDF is priced at $17.93, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, RSMDF's ROE is +0.24%, compared to IMPZY's ROE of +8.77%. Regarding short-term risk, RSMDF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check IMPZY's competition here
RSMDF vs EBRCZ Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, EBRCZ has a market cap of 227M. Regarding current trading prices, RSMDF is priced at $17.93, while EBRCZ trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas EBRCZ's P/E ratio is -1.38. In terms of profitability, RSMDF's ROE is +0.24%, compared to EBRCZ's ROE of -1.80%. Regarding short-term risk, RSMDF is more volatile compared to EBRCZ. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check EBRCZ's competition here
RSMDF vs XVIPY Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, XVIPY has a market cap of 206M. Regarding current trading prices, RSMDF is priced at $17.93, while XVIPY trades at $6.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas XVIPY's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.24%, compared to XVIPY's ROE of +0.01%. Regarding short-term risk, RSMDF is more volatile compared to XVIPY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check XVIPY's competition here
RSMDF vs VMTHF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, VMTHF has a market cap of 186.1M. Regarding current trading prices, RSMDF is priced at $17.93, while VMTHF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas VMTHF's P/E ratio is -3.01. In terms of profitability, RSMDF's ROE is +0.24%, compared to VMTHF's ROE of -0.21%. Regarding short-term risk, RSMDF is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check VMTHF's competition here
RSMDF vs DTXMF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, RSMDF is priced at $17.93, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, RSMDF's ROE is +0.24%, compared to DTXMF's ROE of -0.74%. Regarding short-term risk, RSMDF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.Check DTXMF's competition here
RSMDF vs CLLKF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, CLLKF has a market cap of 157.5M. Regarding current trading prices, RSMDF is priced at $17.93, while CLLKF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas CLLKF's P/E ratio is -1.02. In terms of profitability, RSMDF's ROE is +0.24%, compared to CLLKF's ROE of -0.52%. Regarding short-term risk, RSMDF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check CLLKF's competition here
RSMDF vs JMDMF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, JMDMF has a market cap of 156.4M. Regarding current trading prices, RSMDF is priced at $17.93, while JMDMF trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas JMDMF's P/E ratio is 83.33. In terms of profitability, RSMDF's ROE is +0.24%, compared to JMDMF's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to JMDMF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check JMDMF's competition here
RSMDF vs PXMBF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, PXMBF has a market cap of 149.9M. Regarding current trading prices, RSMDF is priced at $17.93, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, RSMDF's ROE is +0.24%, compared to PXMBF's ROE of -0.03%. Regarding short-term risk, RSMDF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check PXMBF's competition here
RSMDF vs EKDHF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, EKDHF has a market cap of 149.3M. Regarding current trading prices, RSMDF is priced at $17.93, while EKDHF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas EKDHF's P/E ratio is 34.69. In terms of profitability, RSMDF's ROE is +0.24%, compared to EKDHF's ROE of +0.03%. Regarding short-term risk, RSMDF is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check EKDHF's competition here
RSMDF vs EAPIF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, EAPIF has a market cap of 147.5M. Regarding current trading prices, RSMDF is priced at $17.93, while EAPIF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas EAPIF's P/E ratio is -0.60. In terms of profitability, RSMDF's ROE is +0.24%, compared to EAPIF's ROE of -0.24%. Regarding short-term risk, RSMDF is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check EAPIF's competition here
RSMDF vs BCCOY Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, BCCOY has a market cap of 145.1M. Regarding current trading prices, RSMDF is priced at $17.93, while BCCOY trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas BCCOY's P/E ratio is -0.92. In terms of profitability, RSMDF's ROE is +0.24%, compared to BCCOY's ROE of -0.51%. Regarding short-term risk, RSMDF is more volatile compared to BCCOY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check BCCOY's competition here
RSMDF vs AMEUF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, RSMDF is priced at $17.93, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, RSMDF's ROE is +0.24%, compared to AMEUF's ROE of -1.90%. Regarding short-term risk, RSMDF is more volatile compared to AMEUF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check AMEUF's competition here
RSMDF vs SOMNF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, SOMNF has a market cap of 98.6M. Regarding current trading prices, RSMDF is priced at $17.93, while SOMNF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas SOMNF's P/E ratio is -45.00. In terms of profitability, RSMDF's ROE is +0.24%, compared to SOMNF's ROE of -0.05%. Regarding short-term risk, RSMDF is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check SOMNF's competition here
RSMDF vs RSHUF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, RSMDF is priced at $17.93, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, RSMDF's ROE is +0.24%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, RSMDF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.Check RSHUF's competition here
RSMDF vs AVHHL Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, AVHHL has a market cap of 90.1M. Regarding current trading prices, RSMDF is priced at $17.93, while AVHHL trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas AVHHL's P/E ratio is -2.34. In terms of profitability, RSMDF's ROE is +0.24%, compared to AVHHL's ROE of +3.05%. Regarding short-term risk, RSMDF is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check AVHHL's competition here
RSMDF vs CKMTF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, RSMDF is priced at $17.93, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, RSMDF's ROE is +0.24%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, RSMDF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check CKMTF's competition here
RSMDF vs SNZZF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, SNZZF has a market cap of 75M. Regarding current trading prices, RSMDF is priced at $17.93, while SNZZF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas SNZZF's P/E ratio is -5.30. In terms of profitability, RSMDF's ROE is +0.24%, compared to SNZZF's ROE of -0.38%. Regarding short-term risk, RSMDF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check SNZZF's competition here
RSMDF vs BLOZF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, BLOZF has a market cap of 59.8M. Regarding current trading prices, RSMDF is priced at $17.93, while BLOZF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas BLOZF's P/E ratio is -12.19. In terms of profitability, RSMDF's ROE is +0.24%, compared to BLOZF's ROE of -3.03%. Regarding short-term risk, RSMDF is more volatile compared to BLOZF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check BLOZF's competition here
RSMDF vs TLTFF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, TLTFF has a market cap of 44.8M. Regarding current trading prices, RSMDF is priced at $17.93, while TLTFF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas TLTFF's P/E ratio is -16.26. In terms of profitability, RSMDF's ROE is +0.24%, compared to TLTFF's ROE of -3.15%. Regarding short-term risk, RSMDF is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check TLTFF's competition here
RSMDF vs BRNHF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, BRNHF has a market cap of 42.1M. Regarding current trading prices, RSMDF is priced at $17.93, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas BRNHF's P/E ratio is -1.33. In terms of profitability, RSMDF's ROE is +0.24%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, RSMDF is more volatile compared to BRNHF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check BRNHF's competition here
RSMDF vs NVYTF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, NVYTF has a market cap of 34.8M. Regarding current trading prices, RSMDF is priced at $17.93, while NVYTF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas NVYTF's P/E ratio is -0.86. In terms of profitability, RSMDF's ROE is +0.24%, compared to NVYTF's ROE of -1.22%. Regarding short-term risk, RSMDF is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check NVYTF's competition here
RSMDF vs ACIXF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, ACIXF has a market cap of 32.7M. Regarding current trading prices, RSMDF is priced at $17.93, while ACIXF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas ACIXF's P/E ratio is -2.91. In terms of profitability, RSMDF's ROE is +0.24%, compared to ACIXF's ROE of -1.06%. Regarding short-term risk, RSMDF is more volatile compared to ACIXF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check ACIXF's competition here
RSMDF vs RDGL Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, RDGL has a market cap of 32.6M. Regarding current trading prices, RSMDF is priced at $17.93, while RDGL trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas RDGL's P/E ratio is -6.60. In terms of profitability, RSMDF's ROE is +0.24%, compared to RDGL's ROE of -1.48%. Regarding short-term risk, RSMDF is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check RDGL's competition here
RSMDF vs POSC Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, POSC has a market cap of 26.6M. Regarding current trading prices, RSMDF is priced at $17.93, while POSC trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas POSC's P/E ratio is -5.64. In terms of profitability, RSMDF's ROE is +0.24%, compared to POSC's ROE of -7.67%. Regarding short-term risk, RSMDF is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check POSC's competition here
RSMDF vs PYNKF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, PYNKF has a market cap of 26.3M. Regarding current trading prices, RSMDF is priced at $17.93, while PYNKF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas PYNKF's P/E ratio is 4.17. In terms of profitability, RSMDF's ROE is +0.24%, compared to PYNKF's ROE of -2.78%. Regarding short-term risk, RSMDF is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check PYNKF's competition here
RSMDF vs MKEAF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, RSMDF is priced at $17.93, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, RSMDF's ROE is +0.24%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, RSMDF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check MKEAF's competition here
RSMDF vs TCLIF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, TCLIF has a market cap of 25.1M. Regarding current trading prices, RSMDF is priced at $17.93, while TCLIF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas TCLIF's P/E ratio is -4.84. In terms of profitability, RSMDF's ROE is +0.24%, compared to TCLIF's ROE of +2.39%. Regarding short-term risk, RSMDF is less volatile compared to TCLIF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.Check TCLIF's competition here
RSMDF vs KBBTF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, RSMDF is priced at $17.93, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, RSMDF's ROE is +0.24%, compared to KBBTF's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check KBBTF's competition here
RSMDF vs EMITF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, EMITF has a market cap of 21.3M. Regarding current trading prices, RSMDF is priced at $17.93, while EMITF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas EMITF's P/E ratio is -7.62. In terms of profitability, RSMDF's ROE is +0.24%, compared to EMITF's ROE of -0.07%. Regarding short-term risk, RSMDF is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check EMITF's competition here
RSMDF vs VPTDF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, VPTDF has a market cap of 18M. Regarding current trading prices, RSMDF is priced at $17.93, while VPTDF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas VPTDF's P/E ratio is -9.61. In terms of profitability, RSMDF's ROE is +0.24%, compared to VPTDF's ROE of +0.78%. Regarding short-term risk, RSMDF is more volatile compared to VPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check VPTDF's competition here
RSMDF vs DIZTF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, RSMDF is priced at $17.93, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, RSMDF's ROE is +0.24%, compared to DIZTF's ROE of -0.52%. Regarding short-term risk, RSMDF is more volatile compared to DIZTF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check DIZTF's competition here
RSMDF vs GTHP Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, GTHP has a market cap of 17.6M. Regarding current trading prices, RSMDF is priced at $17.93, while GTHP trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas GTHP's P/E ratio is -5.72. In terms of profitability, RSMDF's ROE is +0.24%, compared to GTHP's ROE of +0.71%. Regarding short-term risk, RSMDF is more volatile compared to GTHP. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check GTHP's competition here
RSMDF vs MDXHF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, MDXHF has a market cap of 14.4M. Regarding current trading prices, RSMDF is priced at $17.93, while MDXHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas MDXHF's P/E ratio is -4.40. In terms of profitability, RSMDF's ROE is +0.24%, compared to MDXHF's ROE of +0.66%. Regarding short-term risk, RSMDF is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check MDXHF's competition here
RSMDF vs IPDQF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, IPDQF has a market cap of 14.3M. Regarding current trading prices, RSMDF is priced at $17.93, while IPDQF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas IPDQF's P/E ratio is -0.70. In terms of profitability, RSMDF's ROE is +0.24%, compared to IPDQF's ROE of -1.65%. Regarding short-term risk, RSMDF is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check IPDQF's competition here
RSMDF vs TMDIF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, RSMDF is priced at $17.93, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, RSMDF's ROE is +0.24%, compared to TMDIF's ROE of +8.70%. Regarding short-term risk, RSMDF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.Check TMDIF's competition here
RSMDF vs ASAPF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, ASAPF has a market cap of 13.9M. Regarding current trading prices, RSMDF is priced at $17.93, while ASAPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas ASAPF's P/E ratio is -17.80. In terms of profitability, RSMDF's ROE is +0.24%, compared to ASAPF's ROE of -0.19%. Regarding short-term risk, RSMDF is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check ASAPF's competition here
RSMDF vs ATBPF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, RSMDF is priced at $17.93, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, RSMDF's ROE is +0.24%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, RSMDF is more volatile compared to ATBPF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check ATBPF's competition here
RSMDF vs ALRTF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, ALRTF has a market cap of 11.4M. Regarding current trading prices, RSMDF is priced at $17.93, while ALRTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas ALRTF's P/E ratio is -0.44. In terms of profitability, RSMDF's ROE is +0.24%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, RSMDF is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check ALRTF's competition here
RSMDF vs LXXGF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, RSMDF is priced at $17.93, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, RSMDF's ROE is +0.24%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, RSMDF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check LXXGF's competition here
RSMDF vs PLLWF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, PLLWF has a market cap of 8M. Regarding current trading prices, RSMDF is priced at $17.93, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas PLLWF's P/E ratio is -0.66. In terms of profitability, RSMDF's ROE is +0.24%, compared to PLLWF's ROE of -0.99%. Regarding short-term risk, RSMDF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.Check PLLWF's competition here
RSMDF vs PMEDF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, PMEDF has a market cap of 6.9M. Regarding current trading prices, RSMDF is priced at $17.93, while PMEDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas PMEDF's P/E ratio is -3.33. In terms of profitability, RSMDF's ROE is +0.24%, compared to PMEDF's ROE of +1.24%. Regarding short-term risk, RSMDF is more volatile compared to PMEDF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check PMEDF's competition here
RSMDF vs USAQ Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, USAQ has a market cap of 5.7M. Regarding current trading prices, RSMDF is priced at $17.93, while USAQ trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas USAQ's P/E ratio is 15.47. In terms of profitability, RSMDF's ROE is +0.24%, compared to USAQ's ROE of +0.92%. Regarding short-term risk, RSMDF is more volatile compared to USAQ. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check USAQ's competition here
RSMDF vs QLIS Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, RSMDF is priced at $17.93, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas QLIS's P/E ratio is 2.22. In terms of profitability, RSMDF's ROE is +0.24%, compared to QLIS's ROE of -0.15%. Regarding short-term risk, RSMDF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check QLIS's competition here
RSMDF vs RHNMF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, RSMDF is priced at $17.93, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, RSMDF's ROE is +0.24%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, RSMDF is more volatile compared to RHNMF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check RHNMF's competition here
RSMDF vs BIEL Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, BIEL has a market cap of 5.4M. Regarding current trading prices, RSMDF is priced at $17.93, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas BIEL's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.24%, compared to BIEL's ROE of +0.05%. Regarding short-term risk, RSMDF is more volatile compared to BIEL. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check BIEL's competition here
RSMDF vs ELXMF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, ELXMF has a market cap of 4.1M. Regarding current trading prices, RSMDF is priced at $17.93, while ELXMF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas ELXMF's P/E ratio is -0.72. In terms of profitability, RSMDF's ROE is +0.24%, compared to ELXMF's ROE of -0.40%. Regarding short-term risk, RSMDF is less volatile compared to ELXMF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.Check ELXMF's competition here
RSMDF vs LLBO Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, LLBO has a market cap of 3.9M. Regarding current trading prices, RSMDF is priced at $17.93, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas LLBO's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.24%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, RSMDF is more volatile compared to LLBO. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check LLBO's competition here
RSMDF vs NGMDF Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, NGMDF has a market cap of 3.7M. Regarding current trading prices, RSMDF is priced at $17.93, while NGMDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas NGMDF's P/E ratio is -0.55. In terms of profitability, RSMDF's ROE is +0.24%, compared to NGMDF's ROE of +0.94%. Regarding short-term risk, RSMDF is more volatile compared to NGMDF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check NGMDF's competition here
RSMDF vs ADMT Comparison May 2026
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26B. In comparison, ADMT has a market cap of 3.7M. Regarding current trading prices, RSMDF is priced at $17.93, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 17.24, whereas ADMT's P/E ratio is -5.50. In terms of profitability, RSMDF's ROE is +0.24%, compared to ADMT's ROE of -0.01%. Regarding short-term risk, RSMDF is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.Check ADMT's competition here